Assessment of response to treatment in anemia (iron deficiency) after CABG in adults

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170912036157N2

Enrollment

142

Registered

2020-05-19

Start date

2020-04-19

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic ischemic heart disease. Chronic ischemic heart disease

Interventions

Intervention group: In this study, each patient is placed in the control group first and enters the intervention group after the intervention.First, patients are tested for ferritin, TIBC, and reticul

Eligibility

Sex/Gender

All

Age

18 Years to 72 Years

Inclusion criteria

Inclusion criteria: Age between 18 until 72 years Patients are candidates for CABG for the first time Hemoglobin is less than 10 in women and less than 11 in men

Exclusion criteria

Exclusion criteria: History of previous surgery Kidney disorders Autoimmune diseases Bleeding disorders, Thalassemia

Design outcomes

Secondary

Measure	Time frame
Ferritin level. Timepoint: Before and after treatment. Method of measurement: blood test.	—

Primary

Measure	Time frame
Hemoglobin level. Timepoint: Before and after treatment. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZia Totonchi

Iran University of Medical Sciences

ziya189@yahoo.com+98 21 2392 2153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026